Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A new footprint in California
November 2018
SHARING OPTIONS:

SAN DIEGO—BioDuro LLC kicked off the fourth quarter with the announcement of a new drug discovery center for chemistry and biology in San Diego, which will “help drug developers advance into the clinic with confidence,” according to a press release. The new center will offer oncology and immuno-oncology capabilities built on high-fidelity patient-derived tumor models, such as in-vitro 3D human tumor microenvironment (hTME-3DX Screen and Verify) or in-vivo patient-derived xenograft. It can also provide development of patient-matched tumor/immune cell models, with CMC operations offering drug product development, analytical testing and GMP manufacturing for clinical trial materials.
 
“The addition of the translational oncology site in San Diego allows our oncology clients to study their drugs in real patient-based tumor and immune cell models,” said Thomas B. Broudy, BioDuro’s executive vice president of translational sciences. “These models more accurately represent the clinical population, and that helps our drug development partners to build confident clinical strategies—from cancer type to patient selection to combination approaches.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.